Meteora Capital »

Cidara Therapeutics shares owned by Meteora Capital

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Meteora Capital from 13F filings

Historical chart of Meteora Capital investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Meteora Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Meteora Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $840k 3.8k 220.89

More positions owned by Meteora Capital

M3brigade Acquisition V Corp (MBAV)
Sequans Communications SA Put Put Option (SQNS)
Cantor Equity Partners I (CEPO)
Armada Acquisition Corp Ii (XRPN)
Republic Digital Acquisition (RDAG)
Cantor Equity Partners Iii I (CAEP)
Apex Treas Corp (APXT)
Crane Harbor Acquisition Corp II Unit (CRANU)
Gores Hldgs X (GTEN)
Dynamix Corp (ETHM)
Investcorp Europe Acquisitio (IVCBF)
Cal Redwood Acquisition Corp (CRAQ)
Procap Acquisition Corp (PCAP)
Trailblazer Acquisition Corp (BLZR)
Aurora Innovation Conv

View all positions for Meteora Capital

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
BVF
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics